Identification of T-cell epitopes by a novel mRNA PCR-basedEpitope chase technique

Journal of Immunotherapy

Volumn 34, Issue 2, 2011, Pages 183-186

  Doucet, Jean Daniel ^a   Gauchat, Dominique ^a   Lapointe, Réjean ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

epitope mapping; major histocompatibility complexes of classes I and II; T cell epitope

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; MESSENGER RNA;

ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ELECTROPORATION; EPITOPE MAPPING; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE;

ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS; VIRAL MATRIX PROTEINS;

EID: 79953055593     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e318207ed14     Document Type: Article

References (15)

1. Soethout EC, Meiring HD, Jong APd, et al. Identifying the epitope-specific T cell response to virus infections. Vaccine. 2007;25:3200-3203. (Pubitemid 46482747)
2. Pilla L, Rivoltini L, Patuzzo R, et al. Multipeptide vaccination in cancer patients. Expert Opin Biol Ther. 2009;9:1043-1055.
3. Bakker A, Hoppes R, Linnemann C, et al. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc Natl Acad Sci USA. 2008;105:3825-3830. (Pubitemid 351723484)
4. Engelhard VH. The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes. Int J Mass Spectrom. 2007;259:32-39.
5. Robbins P, el-Gamil M, Li Y, et al. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol. 1995;154:5944-5950.
6. Britten CM, Meyer RG, Graf C, et al. Identification of T cell epitopes by the use of rapidly generated mRNA fragments. J Immunol Methods. 2005;299:165-175. (Pubitemid 40725933)
7. Pelletier S, Tanguay S, Lee S, et al. TGF-alpha as a candidate tumor antigen for renal cell carcinomas. Cancer Immunol Immunother. 2009;58:1207-1218.
8. Lapointe R, Bellemare-Pelletier A, Housseau F, et al. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res. 2003;63:2836-2843. (Pubitemid 36667155)
9. Zhang Q, Wang P, Kim Y, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008;36: W513-W518.
10. Ho O, Green WR. Alternative translational products and cryptic T cell epitopes: expexcting the unexpected. J Immunol. 2006;177:8283-8289. (Pubitemid 44893787)
11. Skipper J, Hendrickson R, Gulden P, et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med. 1996; 183:527-534. (Pubitemid 26059516)
12. Hanada K-I, Yewdell JW, Yang JC. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature. 2004;427:252-256. (Pubitemid 38112041)
13. Fairchild PJ, Pope H, Wraith DC. The nature of cryptic epitopes within the self-antigen myelin basic protein. Int Immunol. 1996;8:1035-1043. (Pubitemid 26235707)
14. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol. 1999;17:51-88. (Pubitemid 29241119)
15. Contreras CE, Ploton IN, Siliciano RF, et al. Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen. Infect Immun. 1998;66:3579-3590. (Pubitemid 28347811)